By Karunjit Singh (January 26, 2024, 12:35 PM EST) -- The Federal Court has prohibited Biogen from using a trademark for an ophthalmological drug, finding that its use of the mark would infringe Novartis’ right in a registered trademark for a drug used to treat the same medical condition....